ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

HIK Hikma Pharmaceuticals Plc

1,981.00
0.00 (0.00%)
10 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Hikma Pharmaceuticals Plc LSE:HIK London Ordinary Share GB00B0LCW083 ORD SHS 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1,981.00 1,985.00 1,987.00 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 2.88B 192M 0.8685 22.81 4.38B
Hikma Pharmaceuticals Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker HIK. The last closing price for Hikma Pharmaceuticals was 1,981p. Over the last year, Hikma Pharmaceuticals shares have traded in a share price range of 1,711.00p to 2,222.00p.

Hikma Pharmaceuticals currently has 221,081,676 shares in issue. The market capitalisation of Hikma Pharmaceuticals is £4.38 billion. Hikma Pharmaceuticals has a price to earnings ratio (PE ratio) of 22.81.

Hikma Pharmaceuticals Share Discussion Threads

Showing 651 to 675 of 1875 messages
Chat Pages: Latest  27  26  25  24  23  22  21  20  19  18  17  16  Older
DateSubjectAuthorDiscuss
07/7/2017
10:14
Dipped toe in here. Upside at some point
richtea2517
07/7/2017
10:05
Looking to buy in, but honestly where is the bottom?

Down nearly another 2% as I type, surprised this has dipped into 1300's

qruz
07/7/2017
09:12
I am following it, but not adding. Graph looks bad and company is very quiet. It should issue an initial trading statement and update on Time scale for applying to FDA again. This may help the share price
karateboy
07/7/2017
08:28
Anyone nibbling
richtea2517
06/7/2017
09:01
If get to around 13.20 I will buy any one know when the next trading statement is
mrthomas
05/7/2017
14:40
Justice - I agree there is nothing from my eyes that warrant such a downfall in the SP, I estimated a few months ago it would go between 1600-1800 check my post history.

They announced obviously the FDA delay will compromise future earnings and had to reduce their forecasts.

I'm eager to enter here but it's down another 1% as I type..

qruz
05/7/2017
14:15
Well I ask again what major disaster has befallen the company to warrant a 50% fall in SP?
justiceforthemany
05/7/2017
12:46
Justice.

A lot of brokers have lowered their guidance, hence the continued sell off, from just so far this week (below).. I'd expect it to continue falling.

WEDNESDAY BROKER ROUND-UP
Hikma Pharmaceuticals: Jefferies reiterates Underweight with a target price of 1390p.

TUESDAY BROKER ROUND-UP
Hikma Pharmaceuticals: HSBC maintains Reduce with a target price of 1410p.

Source from HL.

qruz
05/7/2017
12:39
4 YEAR LOWS HERE.
You have to go back to late 2013-14 to see the share price at these levels.
For no good reason either.

Yet another shorter orchestrated fall. 5.31%

Aside from the delayed approval of a product they never had (!) tell me what other major disaster has befallen this company?

The arabs/CEO Darwazah may well take this back into private ownership.

After all this was 2650p this time last year.

justiceforthemany
03/7/2017
16:48
I wonder if drops is related to Oklohama Atorney General suing few Pharmas....
karateboy
03/7/2017
16:14
yep averaging down soon!
chc15
29/6/2017
13:32
I've added today, hope I'm not averaging down soon!..
chc15
29/6/2017
09:00
I agree it's a good buy, I bought in the last dip before Xmas and sold at earnings for a good profit.

I'm looking to re-enter here but it's free falling every day!

qruz
28/6/2017
22:49
The fact the family own a big portion of the company and it is currently relatively cheap are two of the reasons I bought today !
eastbourne1982
28/6/2017
21:27
The problem for take over is the family who started this company owns the majority shares and they won't sell their baby cheap. I am going to start buying if share price goes below £14.
karateboy
28/6/2017
18:04
Bought in today at £14.79.

For me this is now a takeover candidate, it's a quality business at a very depressed price, throw in the weak pound and it must be tempting for one of the big boys.

This was only two years ago:

hxxp://www.fiercepharma.com/m-a/mylan-said-to-be-eyeing-a-7b-plus-bid-for-rising-star-hikma

eastbourne1982
28/6/2017
11:27
gotta be a bounce here soon???
chc15
28/6/2017
09:24
eps is declining this year.
pyemckay
28/6/2017
09:23
Not sure when the next trading update is but if they can make the same profits as last year for this year the. may be worth buying but of course one would like to see a bottom here as it seems to be in freefall.

The good thing is that it is based in dollars and also it's reasonably profitable and it's got a good cash flow but of course that's all dependent on top line revenue holding up

Like to think as some stage it be a good buy just glad I sold when I did r

mrthomas
28/6/2017
02:04
HSBA, JPM & Cantor
tudes100
27/6/2017
19:51
Who did downgrade the shares Sandeep...?
karateboy
27/6/2017
15:14
Broker forecasts have put the boot in! We need some more info on future products and product approval. Latest RNS give no clue to future financial progress.

Some more Director Buys would also show confidence!

fez77
27/6/2017
14:04
Hikma which has been trading below fair value for some time has now dipped to a new low on news that its CEO is leaving.This could be the final dip. News of a new appointment for the post will rocket the shares higher. I bought in as the up side potential seems like a good bet
ch1ck
27/6/2017
08:25
Some meaty downgrades today
sandeep67
26/6/2017
11:20
Pointless news
qruz
Chat Pages: Latest  27  26  25  24  23  22  21  20  19  18  17  16  Older

Your Recent History

Delayed Upgrade Clock